Arthur B Cohen and Joseph Healey‘s HealthCor Management has filed a 13G with the Securities and Exchange Commission, disclosing its position in Clovis Oncology Inc (NASDAQ:CLVS). The filing showed that Healthcor owns 2.0 million shares of Clovis Oncology, which represent around 5.21% of the company’s outstanding common stock. This compares with the position of 1.53 million shares of Clovis that HealthCor reported in its 13F filing for the end of the last quarter. The fund initiated the position during the last three months of 2015.
However, Clovis Oncology has experienced a decrease in support from the world’s most elite money managers in the fourth quarter. At Q4’s end, a total of 24 of the hedge funds tracked by Insider Monkey held long positions in this stock, down by seven funds over the quarter. When looking at the institutional investors followed by Insider Monkey, Palo Alto Investors, managed by William Leland Edwards, holds the number one position in Clovis Oncology Inc (NASDAQ:CLVS), valued at $124.2 million at the end of 2015. The second largest stake is held by Point State Capital, led by Zach Schreiber, with a $122.6 million position.
Because Clovis Oncology Inc (NASDAQ:CLVS) has witnessed a declination in interest from the smart money, it’s safe to say that there were a few hedge funds that decided to sell off their entire stakes in the third quarter. Interestingly, Andreas Halvorsen’s Viking Global sold off the largest position of all the hedgies followed by Insider Monkey, comprising close to $76.9 million in stock, and Julian Baker and Felix Baker’s Baker Bros. Advisors was right behind this move, as the fund sold off about $18.6 million worth of shares.
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| HealthCor Management | 0 | 2,000,000 | 0 | 2,000,000 | 2,000,000 | 5.21% |
| HealthCor Associates | 0 | 2,000,000 | 0 | 2,000,000 | 2,000,000 | 5.21% |
| HealthCor Offshore Master Fund | 0 | 1,371,065 | 0 | 1,371,065 | 1,371,065 | 3.57% |
| HealthCor Offshore GP | 0 | 1,371,065 | 0 | 1,371,065 | 1,371,065 | 3.57% |
| HealthCor Group | 0 | 2,000,000 | 0 | 2,000,000 | 2,000,000 | 5.21% |
| Arthur Cohen | 0 | 2,000,000 | 0 | 2,000,000 | 2,000,000 | 5.21% |
| Joseph Healey | 0 | 2,000,000 | 0 | 2,000,000 | 2,000,000 | 5.21% |
| HealthCor Sanatate Offshore Master Fund | 0 | 628,935 | 0 | 628,935 | 628,935 | 1.64% |
| HealthCor Offshore II GP | 0 | 628,935 | 0 | 628,935 | 628,935 | 1.64% |
Follow Arthur B Cohen And Joseph Healey's Healthcor Management LP
Page 1 of 15 SEC Filing
SECURITIES & EXCHANGE COMMISSION
Washington, D.C. 20549
———————-
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED
PURSUANT TO RULE 13d-2
(Amendment No.)*
Clovis Oncology, Inc.
(Name of Issuer)
Common Stock, $.001 Par Value Per Share
(Title of Class of Securities)
189464100
(CUSIP
Number)
March
2, 2016
(Date of Event Which Requires Filing of
this Statement)
Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:
| ¨ | Rule 13d-1(b) | |
| x | Rule 13d-1(c) | |
| ¨ | Rule 13d-1(d) |
(Page 1 of 15 Pages)
—————
*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 2 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS HealthCor Management, L.P. |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 2,000,000 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 2,000,000 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 2,000,000 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.21% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 3 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS HealthCor Associates, LLC |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 2,000,000 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 2,000,000 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 2,000,000 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.21% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO – limited liability company |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 4 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS HealthCor Offshore Master Fund, L.P. |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 1,371,065 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 1,371,065 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 1,371,065 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.57% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 5 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS HealthCor Offshore GP, LLC |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 1,371,065 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 1,371,065 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 1,371,065 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.57% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO – limited liability company |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 6 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS HealthCor Group, LLC |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 2,000,000 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 2,000,000 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 2,000,000 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.21% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO – limited liability company |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 7 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS Arthur Cohen |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 2,000,000 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 2,000,000 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 2,000,000 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.21% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 8 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS Joseph Healey |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 2,000,000 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 2,000,000 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 2,000,000 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.21% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 9 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS HealthCor Sanatate Offshore Master Fund, L.P. |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 628,935 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 628,935 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 628,935 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.64% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 10 of 15 SEC Filing
| 1. | NAME OF REPORTING PERSONS HealthCor Offshore II GP, LLC |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 628,935 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 628,935 |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED 628,935 |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW o |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.64% |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO – limited liability company |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 11 of 15 SEC Filing
| Item 1(a). | Name of Issuer: |
Clovis Oncology, Inc.
| Item 1(b). | Address of Issuer’s Principal Executive Offices: |
5500 Flatiron Parkway, Suite 100 Boulder,
Colorado 80301
| Item 2 (a, b, c). | Name of Person Filing: |
| (i) HealthCor Management, L.P., a Delaware limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; |
| (ii) HealthCor Associates, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; |
| (iii) HealthCor Offshore Master Fund, L.P., a Cayman Islands limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; |
| (iv) HealthCor Offshore GP, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; |
| (v) HealthCor Group, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; |
| (vi) Joseph Healey, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; |
| (vii) Arthur Cohen, 12 South Main Street, #203 Norwalk, CT 06854; |
| (viii) HealthCor Sanatate Offshore Master Fund, L.P., a Cayman Islands limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; and |
| (ix) HealthCor Offshore II GP, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019. |
| Both Mr. Healey and Mr. Cohen are United States citizens. |
| The persons at (i) through (ix) above are collectively referred to herein as the “Reporting Persons”. |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 12 of 15 SEC Filing
| Item 2 (d). | Title of Class of Securities: Common Stock, $.001 Par Value Per Share (the “Common Stock”) |
| Item 2 (e). | CUSIP Number: 189464100 |
| Item 3. | Not applicable. |
| Item 4. | Ownership. |
The information required by Items 4(a) – (c) is set
forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting
Person.
Collectively, HealthCor Offshore Master Fund, L.P. and
HealthCor Sanatate Offshore Master Fund, L.P. (each a “Fund” and together, the “Funds”) are the beneficial
owners of a total of 2,000,000 shares of the Common Stock of the Issuer.
HealthCor Offshore GP, LLC is the general partner of
HealthCor Offshore Master Fund, L.P. Accordingly, HealthCor Offshore GP, LLC may be deemed to beneficially own the shares of Common
Stock that are beneficially owned by HealthCor Offshore Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor
Offshore GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor
Offshore Master Fund, L.P.
HealthCor Offshore II GP, LLC is the general partner
of HealthCor Sanatate Offshore Master Fund, L.P. Accordingly, HealthCor Offshore II GP, LLC may be deemed to beneficially own the
shares of Common Stock that are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P. HealthCor Group, LLC is the
managing member of HealthCor Offshore II GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that
are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P.
By virtue of its position as the investment manager
of the Funds, HealthCor Management, L.P. may be deemed a beneficial owner of all the shares of Common Stock owned by the Funds.
HealthCor Associates, LLC is the general partner of HealthCor Management, L.P. and thus may also be deemed to beneficially own
the shares of Common Stock that are beneficially owned by the Funds.
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 13 of 15 SEC Filing
As the Managers of HealthCor Associates, LLC, Arthur
Cohen and Joseph Healey exercise both voting and investment power with respect to the shares of Common Stock reported herein, and
therefore each may be deemed a beneficial owner of such Common Stock.
Each of the Reporting Persons hereby disclaims any beneficial
ownership of any such shares of Common Stock in excess of their actual pecuniary interest therein.
| Item 5. | Ownership of Five Percent or Less of a Class: |
If this statement is being filed to report the fact that
as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the
class of securities, check the following ¨.
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired |
the Security Being Reported on
by the Parent Holding Company.
Not Applicable
| Item 8. | Identification and Classification of Members of the Group. |
See Exhibit I.
| Item 9. | Notice of Dissolution of Group. |
Not Applicable
| Item 10. | Certification. |
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
Exhibits:
| Exhibit I: | Joint Acquisition Statement, dated as of March 8, 2016 |
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 14 of 15 SEC Filing
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true, complete and correct.
DATED: March 8, 2016
| HEALTHCOR MANAGEMENT, L.P. | ||||
| By: HealthCor Associates, LLC, its general partner | ||||
| /s/ Anabelle P. Gray | ||||
| Name: | Anabelle P. Gray | |||
| Title: | General Counsel | |||
| HEALTHCOR OFFSHORE GP, LLC, for itself and as general partner of behalf of HEALTHCOR OFFSHORE MASTER FUND, L.P. | ||||
| By: HealthCor Group, LLC, its managing member | ||||
| /s/ Anabelle P. Gray | ||||
| Name: | Anabelle P. Gray | |||
| Title: | General Counsel | |||
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Page 15 of 15 SEC Filing
| HEALTHCOR OFFSHORE II GP, LLC, for itself and as general partner of behalf of HEALTHCOR SANATATE OFFSHORE MASTER FUND, L.P. | ||||
| By: HealthCor Group, LLC, its managing member | ||||
| /s/ Anabelle P. Gray | ||||
| Name: | Anabelle P. Gray | |||
| Title: | General Counsel | |||
| HEALTHCOR ASSOCIATES, LLC | ||||
| /s/ Anabelle P. Gray | ||||
| Name: | Anabelle P. Gray | |||
| Title: | General Counsel | |||
| HEALTHCOR GROUP, LLC | ||||
| By: /s/ Anabelle P. Gray | ||||
| Name: | Anabelle P. Gray | |||
| Title: | General Counsel | |||
| JOSEPH HEALEY, Individually | ||||
| /s/ Joseph Healey | ||||
| ARTHUR COHEN, Individually | ||||
| /s/ Arthur Cohen | ||||
